How to Import Pharmaceuticals: FDA and DEA Rules

Importing pharmaceuticals into the United States is tightly restricted: a drug generally must be FDA-approved, made in a registered facility, and listed with the FDA before it can lawfully enter, and commercial importation of unapproved or foreign-market versions of a drug is prohibited under the Federal Food, Drug, and Cosmetic Act (FDCA). This is the opposite of most consumer imports — for drugs, the default rule is “no” unless a specific authorization applies. This guide explains who can import what, and the agencies that have to clear it.

The Baseline FDA Rule: Approved, Registered, Listed

The FDA regulates drug imports under the FDCA. For a finished prescription drug to be imported for the U.S. market, three things generally have to be true:

• The drug is FDA-approved (it has an approved New Drug Application or Abbreviated New Drug Application, or is otherwise authorized).
• The manufacturer is registered with the FDA and the product is listed.
• The drug meets U.S. labeling and current Good Manufacturing Practice (cGMP) requirements.

A drug that is approved abroad but not in the United States is, by definition, an unapproved new drug here — and so is a foreign-market version of a U.S.-approved drug (different labeling, packaging, or supply chain). Both are generally inadmissible. The FDA reviews import entries electronically and can issue a “may proceed,” detain the shipment, or refuse admission; products on an FDA import alert can be detained without physical examination.

The Narrow Personal-Importation Exception

People often hear that they can buy cheaper medication abroad. The reality is narrower. The FDA’s Personal Importation Policy is a discretionary enforcement guideline, not a legal right, and it does not make importation lawful — it describes when the FDA may decline to act. The agency has generally exercised that discretion for a small quantity (often about a 90-day supply) of an unapproved drug only when all of the following hold:

This is case-by-case discretion. It is not a route for a business to import drugs for resale, and the FDA can refuse any shipment that does not meet these conditions.

Controlled Substances Add a DEA Layer

If the drug is a controlled substance, the Drug Enforcement Administration regulates it on top of the FDA. The importer must hold a DEA registration as an importer and, for Schedule I and II substances and certain Schedule III–V narcotics, obtain an import permit on DEA Form 357 before the substance enters; other scheduled imports require a DEA Form 236 declaration. These filings go through the DEA Diversion Control Division’s secure system and require the substance’s drug name, NDC number, and DEA controlled-substance code. Skipping the DEA step is a serious violation regardless of FDA status.

Track-and-Trace Under the DSCSA

Prescription drugs in the U.S. supply chain are subject to the Drug Supply Chain Security Act (DSCSA), which requires interoperable, unit-level tracing of products as they change hands. An importer entering the legitimate distribution chain has to be an authorized trading partner and handle product identifiers and transaction data accordingly. This is part of why “gray-market” and parallel imports are so heavily scrutinized — they break the documented chain the DSCSA is built to protect.

Active Ingredients, Devices, and Cosmetics Are Separate

“Pharmaceuticals” is not one category at the border. Active pharmaceutical ingredients (APIs) imported for further manufacturing follow facility-registration and cGMP rules but a different commercial path than finished drugs. Medical devices and cosmetics are regulated under their own FDA frameworks — see our primers on importing medical devices and the broader FDA-regulated import process. Confirm which FDA center governs your product before you classify and enter it, because the HTS code tells CBP which FDA requirements to apply.

Frequently Asked Questions

Can I import prescription drugs into the U.S. to sell?

Generally no. Commercial importation of unapproved drugs — including foreign-market versions of U.S.-approved drugs — is prohibited under the FDCA. A drug must be FDA-approved, made in a registered facility, and listed before it can be imported for the U.S. market.

Is it legal to buy my medication from a foreign pharmacy?

It is not automatically legal. The FDA’s Personal Importation Policy is discretionary enforcement, not authorization, and the agency applies it case-by-case to small personal quantities of drugs for serious conditions with no U.S. alternative. The FDA can refuse any noncompliant shipment.

What extra rules apply to controlled substances?

The importer needs a DEA registration and, for many schedules, an import permit on DEA Form 357 (or a Form 236 declaration) filed before entry, in addition to all FDA requirements.

Who is responsible if an imported drug shipment is noncompliant?

The importer of record, under the duty of reasonable care — even when a broker files the entry. The FDA can detain or refuse the goods, and DEA or civil penalties may follow for controlled-substance violations.

Drug importation is a default-prohibited area where the authorizations, not the goods, do the work. Reidel Law Firm helps importers confirm FDA and DEA requirements before they commit, on flat-fee terms with a plain-English compliance memo and direct attorney access. Get an import compliance memo.